Tobramycin/fosfomycin inhalationAlternative Names: Corus 1040; GS 9310/11; Inhaled fosfomycin/tobramycin
Latest Information Update: 24 Feb 2014
At a glance
- Originator Gilead Sciences
- Class Aminoglycosides; Antibacterials; Epoxy compounds; Organophosphorus compounds; Phosphonic acids; Small molecules
- Mechanism of Action Cell wall inhibitors; Protein 30S ribosomal subunit inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Bronchiectasis; Cystic fibrosis-associated respiratory tract infections